REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioavances S.A.S. (Ecuador)

Main Activities: Other Scientific and Technical Consulting Services
Full name: Bioavances S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Bioavances S.A.S. is an enterprise based in Ecuador. Its main office is in Guayaquil. The company operates in the Other Scientific and Technical Consulting Services industry. The enterprise was incorporated on August 08, 2022. The total number of employees is currently 2 (2024). From the latest financial highlights, Bioavances S.A.S. reported a net sales revenue increase of 81.11% in 2025. During that time, Bioavances S.A.S.’s total assets grew by 5.08%. The net profit margin of Bioavances S.A.S. decreased by 27.09% in 2025.

Headquarters
Calle Principal B, 20
Guayaquil; Guayas;

Contact Details: Purchase the Bioavances S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Bioavances S.A.S. report to view the information.
Registered Capital:
Purchase the Bioavances S.A.S. report to view the information.
Financial Auditors:
Purchase the Bioavances S.A.S. report to view the information.
Incorporation Date:
August 08, 2022
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Oncobiotec S.A.
34%
Company Performance
Financial values in the chart are available after Bioavances S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
81.11%
Total Operating Revenue
81.11%
Operating Profit
-49.63%
EBITDA
-49.63%
Net Profit/Loss for the Period
-49.32%
Total Assets
5.08%
Total Equity
12.32%
Operating Profit Margin
-35.34%
Net Profit Margin
-27.09%
Return on Equity (ROE)
-13.34%
Quick Ratio
22.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?